119 related articles for article (PubMed ID: 29749486)
1. Effects of obatoclax combined with gemcitabine on the biological activity of pancreatic cancer cells under hypoxic conditions.
Hou XF; Li S; Wu C; Li K; Xu SN; Wang JF
Mol Med Rep; 2018 Jul; 18(1):495-501. PubMed ID: 29749486
[TBL] [Abstract][Full Text] [Related]
2. [Effects of obatoclax combined with gemcitabine on breast cancer cells under hypoxia condition].
Song HY; Zhang YM; Lian H; Zhou L
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2020 May; 36(3):268-272. PubMed ID: 32981284
[No Abstract] [Full Text] [Related]
3. Hyperthermia inhibits the motility of gemcitabine-resistant pancreatic cancer PANC-1 cells through the inhibition of epithelial-mesenchymal transition.
Jin H; Zhao Y; Zhang S; Yang J; Zhang X; Ma S
Mol Med Rep; 2018 May; 17(5):7274-7280. PubMed ID: 29568909
[TBL] [Abstract][Full Text] [Related]
4. Epigallocatechin-3-Gallate (EGCG) Suppresses Pancreatic Cancer Cell Growth, Invasion, and Migration partly through the Inhibition of Akt Pathway and Epithelial-Mesenchymal Transition: Enhanced Efficacy when Combined with Gemcitabine.
Wei R; Penso NEC; Hackman RM; Wang Y; Mackenzie GG
Nutrients; 2019 Aug; 11(8):. PubMed ID: 31405071
[TBL] [Abstract][Full Text] [Related]
5. Curcumin inhibits pancreatic cancer cell invasion and EMT by interfering with tumor‑stromal crosstalk under hypoxic conditions via the IL‑6/ERK/NF‑κB axis.
Li W; Sun L; Lei J; Wu Z; Ma Q; Wang Z
Oncol Rep; 2020 Jul; 44(1):382-392. PubMed ID: 32377752
[TBL] [Abstract][Full Text] [Related]
6. HDAC inhibitors, trichostatin A and valproic acid, increase E‑cadherin and vimentin expression but inhibit migration and invasion of cholangiocarcinoma cells.
Wang JH; Lee EJ; Ji M; Park SM
Oncol Rep; 2018 Jul; 40(1):346-354. PubMed ID: 29767267
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of miR-210 involved in epithelial-mesenchymal transition of pancreatic cancer cells under hypoxia.
Ni J; Zhou S; Yuan W; Cen F; Yan Q
J Recept Signal Transduct Res; 2019; 39(5-6):399-406. PubMed ID: 31875764
[No Abstract] [Full Text] [Related]
8. Curcumin inhibits hypoxia-induced epithelial‑mesenchymal transition in pancreatic cancer cells via suppression of the hedgehog signaling pathway.
Cao L; Xiao X; Lei J; Duan W; Ma Q; Li W
Oncol Rep; 2016 Jun; 35(6):3728-34. PubMed ID: 27035865
[TBL] [Abstract][Full Text] [Related]
9. The effects of novel chitosan-targeted gemcitabine nanomedicine mediating cisplatin on epithelial mesenchymal transition, invasion and metastasis of pancreatic cancer cells.
Yu H; Song H; Xiao J; Chen H; Jin X; Lin X; Pan B; Ji W
Biomed Pharmacother; 2017 Dec; 96():650-658. PubMed ID: 29035831
[TBL] [Abstract][Full Text] [Related]
10. Local Delivery of Gemcitabine Inhibits Pancreatic and Cholangiocarcinoma Tumor Growth by Promoting Epidermal Growth Factor Receptor Degradation.
Jang SI; Fang S; Baek YY; Lee DH; Na K; Lee SY; Lee DK
Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32111094
[TBL] [Abstract][Full Text] [Related]
11. Pseudolaric Acid B Inhibits Proliferation, Invasion and Epithelial-to-Mesenchymal Transition in Human Pancreatic Cancer Cell.
Li X; Zhao X; Song W; Tian Z; Yang L; Niu Q; Zhang Q; Xie M; Zhou B; Xu Y; Wu J; Zhang C
Yonsei Med J; 2018 Jan; 59(1):20-27. PubMed ID: 29214772
[TBL] [Abstract][Full Text] [Related]
12. Gemcitabine resistance is associated with epithelial-mesenchymal transition and induction of HIF-1α in pancreatic cancer cells.
Wang R; Cheng L; Xia J; Wang Z; Wu Q; Wang Z
Curr Cancer Drug Targets; 2014; 14(4):407-17. PubMed ID: 24575976
[TBL] [Abstract][Full Text] [Related]
13. [Experimental study of the function of nuclear factor-κB-dependent epithelial to mesenchymal transition in pancreatic cancer cells under hypoxic conditions].
Cheng ZX; Sun B; Wang SJ; Zhou HX; Jia G; Kong R; Wang G; Jiang HC
Zhonghua Wai Ke Za Zhi; 2012 May; 50(5):446-51. PubMed ID: 22883954
[TBL] [Abstract][Full Text] [Related]
14. Synergistic interaction of novel lactate dehydrogenase inhibitors with gemcitabine against pancreatic cancer cells in hypoxia.
Maftouh M; Avan A; Sciarrillo R; Granchi C; Leon LG; Rani R; Funel N; Smid K; Honeywell R; Boggi U; Minutolo F; Peters GJ; Giovannetti E
Br J Cancer; 2014 Jan; 110(1):172-82. PubMed ID: 24178759
[TBL] [Abstract][Full Text] [Related]
15. DKK3 blocked translocation of β-catenin/EMT induced by hypoxia and improved gemcitabine therapeutic effect in pancreatic cancer Bxpc-3 cell.
Guo Q; Qin W
J Cell Mol Med; 2015 Dec; 19(12):2832-41. PubMed ID: 26395974
[TBL] [Abstract][Full Text] [Related]
16. Chemosensitization and inhibition of pancreatic cancer stem cell proliferation by overexpression of microRNA-205.
Chaudhary AK; Mondal G; Kumar V; Kattel K; Mahato RI
Cancer Lett; 2017 Aug; 402():1-8. PubMed ID: 28536008
[TBL] [Abstract][Full Text] [Related]
17. Hypoxic Conditions Promote Gemcitabine Sensitivity in a Pancreatic Cancer Stem Cell Line.
Imaizumi A; Onishi H; Yamasaki A; Kawamoto M; Umebayashi M; Morisaki T; Hasumi K
Anticancer Res; 2016 Feb; 36(2):653-7. PubMed ID: 26851020
[TBL] [Abstract][Full Text] [Related]
18. Induction of pancreatic cancer cell apoptosis, invasion, migration, and enhancement of chemotherapy sensitivity of gemcitabine, 5-FU, and oxaliplatin by hnRNP A2/B1 siRNA.
Gu WJ; Liu HL
Anticancer Drugs; 2013 Jul; 24(6):566-76. PubMed ID: 23525071
[TBL] [Abstract][Full Text] [Related]
19. Clobenpropit enhances anti-tumor effect of gemcitabine in pancreatic cancer.
Paik WH; Ryu JK; Jeong KS; Park JM; Song BJ; Lee SH; Kim YT; Yoon YB
World J Gastroenterol; 2014 Jul; 20(26):8545-57. PubMed ID: 25024609
[TBL] [Abstract][Full Text] [Related]
20. Emodin reverses gemcitabine resistance in pancreatic cancer cells via the mitochondrial apoptosis pathway in vitro.
Liu DL; Bu H; Li H; Chen H; Guo HC; Wang ZH; Tong HF; Ni ZL; Liu HB; Lin SZ
Int J Oncol; 2012 Apr; 40(4):1049-57. PubMed ID: 22159556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
